RHYTHM PHARMACEUTICALS, INC. Other Comprehensive Income (Loss), Net of Tax
RHYTHM PHARMACEUTICALS, INC. (RYTM) reported Other Comprehensive Income (Loss), Net of Tax of -$140.59 million for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-02.
Discontinued › Income Statement
us-gaap:OtherComprehensiveIncomeLossNetOfTax · last filed 2020-03-02
- RHYTHM PHARMACEUTICALS, INC. other comprehensive income (loss), net of tax for fiscal 2019 was -$140.59M.
- RHYTHM PHARMACEUTICALS, INC. other comprehensive income (loss), net of tax for fiscal 2018 was -$74.06M.
- RHYTHM PHARMACEUTICALS, INC. other comprehensive income (loss), net of tax for fiscal 2017 was -$33.71M.
| Period end | Other Comprehensive Income (Loss), Net of Tax 12 month |
|---|---|
| 2019-12-31 | -$140.59M 10-K · filed 2020-03-02 |
| 2018-12-31 | -$74.06M 10-K · filed 2020-03-02 |
| 2017-12-31 | -$33.71M 10-K · filed 2020-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |